Strontium sulfate (CAS NO : 2140110)

Strontium sulfate (CAS 7759-02-6) is increasingly utilized as a high purity fine chemical in the United States healthcare sector, particularly for medical imaging contrast agents and bone density pharmaceutical formulations where Pharma/API purity 99% is required. US-based CDMOs are increasingly leveraging custom synthesis services to ensure stringent USP compliance as the industry pivots toward domestic supply chains to mitigate global sourcing risks. Sulfuric acid, strontium salt serves the robust North American industrial sector, specifically in high-performance paints and coatings and specialized glass manufacturing at a General Industry purity 98%. As a leading bulk chemical supplier, we observe that US manufacturers in the API intermediates market are prioritizing localized technical support and rigorous COA documentation to meet evolving regulatory standards. Celestine is gaining significant traction in the advanced ceramics and electronic components space, where its thermal stability and low solubility make it indispensable for next-generation material science applications. The shift toward higher-spec, specification-critical products in the United States is driving demand for specialized synthesis that ensures minimal impurity carry-over for downstream manufacturers. We are an established Strontium sulfate intermediates supplier with >= 99% purity in the united states, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting Strontium sulfate COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities